Prognostic significance of the number of tumor (+) N2 nodes in N2 stage IIIA non-small cell lung cancer after curative resection.

被引：0
|
作者：
Yoo, C.
Yoon, S.
Lee, D.
Suh, C.
Lee, J.
Park, S.
Kim, D.
Kim, Y.
Kim, W.
Kim, S.
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac Surg, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulmonol & Crit Care Med, Seoul, South Korea
[4] Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.7023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7023
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prognostic factors of N2 positive stage IIIA non-small cell lung cancer treated with preoperative concurrent radiochemotherapy and surgery
    Ahn, Y
    Kim, K
    Nam, H
    Oh, D
    Park, Y
    Lim, D
    Han, J
    Park, J
    Kim, J
    Kim, K
    [J]. LUNG CANCER, 2005, 49 : S165 - S165
  • [32] Prognostic Advantage by postoperative Radiation Therapy in addition to adjuvant Chemotherapy in non-small Cell Lung Cancer in Stage IIIA/N2
    Nieder, Carsten
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (06) : 539 - 540
  • [33] Skip mediastinal nodal metastases in the IIIA/N2 non-small cell lung cancer
    Ilic, N
    Petricevic, A
    Tanfara, S
    Kotarac, S
    Arar, D
    Mise, K
    Ilic, NF
    Banovic, J
    [J]. LUNG CANCER, 2005, 49 : S281 - S281
  • [34] Skip mediastinal nodal metastases in the IIIA/N2 non-small cell lung cancer
    Illic, N.
    Petricevic, A.
    Arar, D.
    Kotarac, S.
    Banovic, J.
    Frieta Ilic, N.
    Tripkovic, A.
    Ercegovic, M.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 328 - 328
  • [35] Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer
    Jeremic, Branislav
    Casas, Francesc
    Dubinsky, Pavol
    Gomez-Caamano, Antonio
    Cihoric, Nikola
    Videtic, Gregory
    Igrutinovic, Ivan
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
  • [36] The Significance of Upfront Knowledge of N2 Disease in Non-small Cell Lung Cancer
    Daniel C. Thomas
    Brian N. Arnold
    Joshua E. Rosen
    Michelle C. Salazar
    Frank C. Detterbeck
    Justin D. Blasberg
    Daniel J. Boffa
    Anthony W. Kim
    [J]. World Journal of Surgery, 2018, 42 : 161 - 171
  • [37] The Significance of Upfront Knowledge of N2 Disease in Non-small Cell Lung Cancer
    Thomas, Daniel C.
    Arnold, Brian N.
    Rosen, Joshua E.
    Salazar, Michelle C.
    Detterbeck, Frank C.
    Blasberg, Justin D.
    Boffa, Daniel J.
    Kim, Anthony W.
    [J]. WORLD JOURNAL OF SURGERY, 2018, 42 (01) : 161 - 171
  • [38] The significance of N2 node involvement at thoracotomy in non-small cell lung cancer
    Old, SE
    Gilligan, D
    Laroche, CM
    [J]. THORAX, 1999, 54 : A19 - A19
  • [39] Prognostic Factors in Patients with Pathological and N2 Non-Small Cell Lung Cancer
    Saito, Makoto
    Kato, Harubumi
    [J]. ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 14 (01) : 1 - 2
  • [40] Prognostic Factors for Surgically Resected N2 Non-small Cell Lung Cancer
    Kawasaki, Keishi
    Sato, Yasunori
    Suzuki, Yoshio
    Saito, Haruhisa
    Nomura, Yukihiro
    Yoshida, Yukihiro
    [J]. ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 21 (03) : 217 - 222
12345